[
    [
        {
            "time": "",
            "original_text": "金域医学上市首年业绩增速放缓 布局基因检测谋求突破行业天花板",
            "features": {
                "keywords": [
                    "金域医学",
                    "上市首年",
                    "业绩增速放缓",
                    "基因检测",
                    "行业天花板"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学上市首年业绩增速放缓 布局基因检测谋求突破行业天花板",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[增持评级]金域医学(603882)年报点评：从专注于检验服务到布局全产业链 未来业绩可期",
            "features": {
                "keywords": [
                    "金域医学",
                    "年报",
                    "检验服务",
                    "全产业链",
                    "未来业绩可期"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级]金域医学(603882)年报点评：从专注于检验服务到布局全产业链 未来业绩可期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]